Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains

Crimean Congo hemorrhagic fever virus (CCHFV) is a deadly human pathogen that evades innate immune responses by efficiently interfering with antiviral signaling pathways mediated by NF-κB, IRF3, and IFNα/β. These pathways rely on protein ubiquitination for their activation, and one outcome is the modification of proteins with the ubiquitin (Ub)-like modifier interferon-stimulated gene (ISG)15. CCHFV and related viruses encode a deubiquitinase (DUB) of the ovarian tumor (OTU) family, which unlike eukaryotic OTU DUBs also targets ISG15 modifications. Here we characterized the viral OTU domain of CCHFV (vOTU) biochemically and structurally, revealing that it hydrolyzes four out of six tested Ub linkages, but lacks activity against linear and K29-linked Ub chains. vOTU cleaved Ub and ISG15 with similar kinetics, and we were able to understand vOTU cross-reactivity at the molecular level from crystal structures of vOTU in complex with Ub and ISG15. An N-terminal extension in vOTU not present in eukaryotic OTU binds to the hydrophobic Ile44 patch of Ub, which results in a dramatically different Ub orientation compared to a eukaryotic OTU–Ub complex. The C-terminal Ub-like fold of ISG15 (ISG15-C) adopts an equivalent binding orientation. Interestingly, ISG15-C contains an additional second hydrophobic surface that is specifically contacted by vOTU. These subtle differences in Ub/ISG15 binding allowed the design of vOTU variants specific for either Ub or ISG15, which will be useful tools to understand the relative contribution of ubiquitination vs. ISGylation in viral infection. Furthermore, the crystal structures will allow structure-based design of antiviral agents targeting this enzyme.

[1]  Zhijian J. Chen,et al.  Emerging Role of ISG15 in Antiviral Immunity , 2010, Cell.

[2]  J. Chin,et al.  Engineered diubiquitin synthesis reveals Lys29-isopeptide specificity of an OTU deubiquitinase. , 2010, Nature chemical biology.

[3]  David Komander,et al.  Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne , 2010, Nature Structural &Molecular Biology.

[4]  J. Huibregtse,et al.  The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15 , 2010, Molecular Cell.

[5]  Zhijian J. Chen,et al.  Reconstitution of the RIG-I Pathway Reveals a Signaling Role of Unanchored Polyubiquitin Chains in Innate Immunity , 2010, Cell.

[6]  A. Bowie,et al.  Sensing and Signaling in Antiviral Innate Immunity , 2010, Current Biology.

[7]  S. Nichol,et al.  Crimean-Congo Hemorrhagic Fever Virus-Encoded Ovarian Tumor Protease Activity Is Dispensable for Virus RNA Polymerase Function , 2009, Journal of Virology.

[8]  D. Komander The emerging complexity of protein ubiquitination. , 2009, Biochemical Society transactions.

[9]  Zhijian J. Chen,et al.  Direct Activation of Protein Kinases by Unanchored Polyubiquitin Chains , 2009, Nature.

[10]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[11]  Zhijian J. Chen,et al.  The role of ubiquitin in NF-kappaB regulatory pathways. , 2009, Annual review of biochemistry.

[12]  P. Lehner,et al.  Viral avoidance and exploitation of the ubiquitin system , 2009, Nature Cell Biology.

[13]  David Komander,et al.  Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains , 2009, EMBO reports.

[14]  E. Fiebiger,et al.  Structural basis and specificity of human otubain 1-mediated deubiquitination. , 2009, The Biochemical journal.

[15]  S. Akira,et al.  Involvement of linear polyubiquitylation of NEMO in NF-κB activation , 2009, Nature Cell Biology.

[16]  F. Weber,et al.  Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis , 2008, Cytokine & Growth Factor Reviews.

[17]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[18]  R. Shiekhattar,et al.  Structural Basis for Ubiquitin Recognition by the Otu1 Ovarian Tumor Domain Protein* , 2008, Journal of Biological Chemistry.

[19]  Shannon L. Taylor,et al.  Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin- and ISG15-Dependent Innate Immune Responses , 2007, Cell Host & Microbe.

[20]  E. Pietras,et al.  A Deubiquitinase That Regulates Type I Interferon Production , 2007, Science.

[21]  Robert Ménard,et al.  Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease , 2007, Archives of Biochemistry and Biophysics.

[22]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[23]  Dong-er Zhang,et al.  ISG15: a ubiquitin-like enigma. , 2005, Frontiers in bioscience : a journal and virtual library.

[24]  A. Haas,et al.  Crystal Structure of the Interferon-induced Ubiquitin-like Protein ISG15*[boxs] , 2005, Journal of Biological Chemistry.

[25]  Somasekar Seshagiri,et al.  De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.

[26]  D. Wallach Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. , 2004 .

[27]  H. Ploegh,et al.  Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. , 2002, Chemistry & biology.

[28]  Dong-er Zhang,et al.  UBP43 (USP18) Specifically Removes ISG15 from Conjugated Proteins* , 2002, The Journal of Biological Chemistry.

[29]  J. Ziebuhr,et al.  Virus-encoded proteinases and proteolytic processing in the Nidovirales. , 2000, The Journal of general virology.